| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
139-351 |
DRI_Background |
denotes |
HMC05 is a formulation derived from eight medicinal herbs, and prevents neointima formation by inhibition of the mitogen-activated protein kinase (MAPK) pathway with induction of heat shock protein 27 expression. |
| T2 |
352-423 |
DRI_Challenge |
denotes |
In this study, we investigated the influence of HMC05 regulation on the |
| T3 |
460-593 |
DRI_Challenge |
denotes |
kinase (ERK) 1/2 signaling cascade in the inhibition of the migration and proliferation of human aortic smooth muscle cells (HASMCs). |
| T4 |
956-1166 |
DRI_Background |
denotes |
HMC05 prevented TNF-α receptor 1-mediated phosphorylation of signal transduction molecules involved in MAPK signaling cascades such as MEK1/2, ERK1/2, Elk-1 transcription factor and p90 kDa ribosomal S6 kinase. |
| T5 |
1167-1429 |
DRI_Background |
denotes |
The expression of matrix metalloproteinase, a modulator of vascular smooth muscle cell proliferation and migration, was inhibited by HMCO5 treatment, as was TNF-α-induced mRNA expression of intracellular adhesion molecule 1 and vascular cell adhesion molecule 1. |
| T6 |
1430-1531 |
DRI_Approach |
denotes |
HMC05 disruption of the MEK/ERK/Elk-1 and p90RSK pathways prevents HASMC migration and proliferation. |